| scholarly article | Q13442814 |
| P50 | author | Eric Lander | Q970550 |
| Harvey Lodish | Q5677403 | ||
| Jo-Anne Vergilio | Q115916181 | ||
| P2093 | author name string | Stuart H Orkin | |
| Peng Ji | |||
| Tobias F Menne | |||
| Jinkuk Kim | |||
| Prathapan Thiru | |||
| Vijay G Sankaran | |||
| Danilo Šćepanović | |||
| P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| A gene atlas of the mouse and human protein-encoding transcriptomes | Q24568043 | ||
| A HaemAtlas: characterizing gene expression in differentiated human blood cells | Q24646314 | ||
| MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors | Q24653639 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia | Q28269786 | ||
| Global regulation of erythroid gene expression by transcription factor GATA-1 | Q28275891 | ||
| Developmental and species-divergent globin switching are driven by BCL11A | Q28506497 | ||
| A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen | Q29615061 | ||
| ENCODE whole-genome data in the UCSC Genome Browser | Q33516102 | ||
| Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling | Q33695715 | ||
| DEVELOPMENTAL HEMOGLOBIN ANOMALIES IN A CHROMOSOMAL TRIPLICATION: D1 TRISOMY SYNDROME | Q34425268 | ||
| Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis | Q34630922 | ||
| Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis | Q36453536 | ||
| The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells | Q37066209 | ||
| Ontogeny of erythropoiesis in the mammalian embryo. | Q37087619 | ||
| The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies | Q37259226 | ||
| Control of fetal hemoglobin: new insights emerging from genomics and clinical implications | Q37379477 | ||
| c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. | Q37439625 | ||
| Advances in the understanding of haemoglobin switching | Q37702418 | ||
| MicroRNAs in erythropoiesis | Q37705918 | ||
| Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. | Q39908659 | ||
| Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. | Q39918427 | ||
| Clinical delineation of proximal and distal partial 13q trisomy | Q40109534 | ||
| Coordination of erythropoiesis by the transcription factor c-Myb. | Q42041452 | ||
| Phenotype-karyotype correlation in patients trisomic for various segments of chromosome 13. | Q42105357 | ||
| c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. | Q42946150 | ||
| Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage | Q44788049 | ||
| Postnatal fetal and adult hemoglobin synthesis in D 1 trisomy syndrome | Q48027395 | ||
| Arabinosylcytosine Induces Fetal Hemoglobin in Baboons by Perturbing Erythroid Cell Differentiation Kinetics | Q53552519 | ||
| cMYB is involved in the regulation of fetal hemoglobin production in adults. | Q54591078 | ||
| Trisomy 13 and trisomy 18 in a defined population: epidemiological, genetic and prenatal observations | Q57492877 | ||
| A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis | Q59098583 | ||
| Sickle Cell Disease at 100 Years | Q59555153 | ||
| Persistence of Hemoglobin F in D/D Translocation With Trisomy 13-15 (D1) | Q72344928 | ||
| FOETAL HAEMOGLOBIN AND NEUTROPHIL ANOMALY IN THE D1-TRISOMY SYNDROME | Q76890689 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 1519-24 | |
| P577 | publication date | 2011-01-25 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13 | |
| P478 | volume | 108 |
| Q38979398 | 12p microRNA expression in fibroblast cell lines from probands with Pallister-Killian syndrome |
| Q50061698 | 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts. |
| Q35001653 | A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression |
| Q42711553 | A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia |
| Q37264387 | A feedback loop consisting of microRNA 23a/27a and the β-like globin suppressors KLF3 and SP1 regulates globin gene expression |
| Q47261747 | A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression |
| Q36238248 | A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease |
| Q58751966 | ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin |
| Q36803829 | Advances in understanding erythropoiesis: evolving perspectives |
| Q33864534 | Altered translation of GATA1 in Diamond-Blackfan anemia |
| Q37993118 | Alternative options for DNA-based experimental therapy of β-thalassemia. |
| Q27023172 | Anemia: progress in molecular mechanisms and therapies |
| Q47396521 | BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression |
| Q37071189 | Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease |
| Q38436374 | Changes in lncRNAs and related genes in β-thalassemia minor and β-thalassemia major |
| Q36335791 | Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis |
| Q45888439 | Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia |
| Q50897207 | Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea. |
| Q47147613 | Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications |
| Q90196898 | Construction and Analysis of a Long Non-Coding RNA (lncRNA)-Associated ceRNA Network in β-Thalassemia and Hereditary Persistence of Fetal Hemoglobin |
| Q26750906 | Current and future alternative therapies for beta-thalassemia major |
| Q36240926 | Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number |
| Q36041465 | Defining the Minimal Factors Required for Erythropoiesis through Direct Lineage Conversion |
| Q38676360 | Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice |
| Q50014921 | Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome. |
| Q36759840 | Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model |
| Q35759986 | Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development |
| Q61954916 | Effects of iron supplements and perinatal factors on fetal hemoglobin disappearance in LBW infants |
| Q36384651 | Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma |
| Q38993825 | Emerging cellular and gene therapies for congenital anemias. |
| Q50929191 | Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes. |
| Q35553378 | Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia |
| Q26864609 | Epigenetic regulation of fetal globin gene expression in adult erythroid cells |
| Q26822810 | Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies |
| Q30249259 | Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies |
| Q45874514 | Fetal haemoglobin induction in sickle cell disease |
| Q35114500 | Fetal hemoglobin in sickle cell anemia |
| Q39453785 | Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents |
| Q58776995 | Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain |
| Q38995849 | Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches |
| Q26860339 | From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications |
| Q64283450 | Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis |
| Q50061134 | Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease |
| Q52425959 | Genetic disruption of the KLF1 gene to overexpress the γ-globin gene using the CRISPR/Cas9 system. |
| Q36035471 | Genetic modifiers of sickle cell disease |
| Q38432350 | Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin |
| Q38088060 | Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis |
| Q35087288 | Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach |
| Q38592271 | HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers |
| Q38875745 | Hemoglobin genetics: recent contributions of GWAS and gene editing |
| Q36777717 | Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease |
| Q34322542 | Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? |
| Q64889279 | Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa. |
| Q37397301 | Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets |
| Q37983889 | Involvement of miRNA in erythroid differentiation |
| Q91906433 | Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis |
| Q92494489 | MIR29B mediates epigenetic mechanisms of HBG gene activation |
| Q39742982 | MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. |
| Q36403940 | MiR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells |
| Q37663576 | Micro RNAs and DNA methylation are regulatory players in human cells with altered X chromosome to autosome balance |
| Q38741446 | MicroRNA 200a inhibits erythroid differentiation by targeting PDCD4 and THRB. |
| Q26766931 | MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin |
| Q36031645 | MicroRNA-15/16 Antagonizes Myb To Control NK Cell Maturation |
| Q37190977 | MicroRNA-363 and GATA-1 are regulated by HIF-1α in K562 cells under hypoxia |
| Q34673170 | MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A. |
| Q33987959 | MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis |
| Q64041638 | MicroRNAs and Long Non-coding RNAs in Genetic Diseases |
| Q37988887 | MicroRNAs as components of regulatory networks controlling erythropoiesis |
| Q35745477 | MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease |
| Q38012309 | MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment |
| Q37853929 | MicroRNAs: Allies or foes in erythropoiesis? |
| Q37107194 | Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine |
| Q38912977 | Modulation of microRNAs expression in hematopoietic stem cells treated with sodium butyrate in inducing fetal hemoglobin expression |
| Q39399184 | Molecular basis of β thalassemia and potential therapeutic targets |
| Q50448619 | Molecular signature of erythroblast enucleation in human embryonic stem cells. |
| Q41232448 | Multiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies. |
| Q42381246 | Normal hematologic parameters and fetal hemoglobin silencing with heterozygous IKZF1 mutations |
| Q35139933 | Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells |
| Q37107187 | Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells |
| Q54585888 | Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations |
| Q33602602 | PGC-1 coactivator activity is required for murine erythropoiesis |
| Q38939602 | Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells |
| Q90029300 | Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia |
| Q26851586 | Primitive and definitive erythropoiesis in mammals |
| Q38035829 | Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders |
| Q41973193 | Recent advances in β-thalassemias |
| Q37948111 | Recent patents on therapeutic applications of the transcription factor decoy approach |
| Q45875308 | Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies |
| Q38220695 | Recent trends for novel options in experimental biological therapy of β-thalassemia |
| Q38367473 | Recent trends in the gene therapy of β-thalassemia |
| Q33669301 | Reciprocal regulation of γ-globin expression by exo-miRNAs: Relevance to γ-globin silencing in β-thalassemia major. |
| Q34746087 | Retracted: Eafs Control Erythroid Cell Fate by Regulating c-myb Expression through Wnt Signaling |
| Q38635450 | Society for Pediatric Research 2015 Young Investigator Award: genetics of human hematopoiesis-what patients can teach us about blood cell production |
| Q36450196 | Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells |
| Q36488272 | The switch from fetal to adult hemoglobin |
| Q44223235 | Therapeutic advances in sickle cell disease in the last decade |
| Q35112203 | Transcription factor networks in erythroid cell and megakaryocyte development |
| Q37333153 | Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny |
| Q37122360 | Transcriptional mechanisms underlying hemoglobin synthesis |
| Q36285408 | Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci. |
| Q38057685 | microRNAs: fine tuning of erythropoiesis. |
Search more.